Facebook
Twitter
LinkedIn
ForwardPulse - Community-Acquired Respiratory Viruses in Lung Transplant Recipients: CARV’ing Out Treatment and Management Strategies
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Community acquired respiratory viruses (CARVs) commonly infect lung transplant recipients which results in significant morbidity and mortality. This education will discuss emerging literature regarding treatment methods for these infections.
Target Audience
Pharmacist
Learning Objectives
1. Identify community acquired respiratory viruses (CARVs) that commonly infect lung transplant patients
2. Describe consequences of CARVs infection in lung transplant recipients
3. Discuss current literature about treatment methods for CARVs in lung transplant recipients
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_5.pptx | 459.39 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Community acquired respiratory viruses (CARVs) commonly infect lung transplant recipients which results in significant morbidity and mortality. This education will discuss emerging literature regarding treatment methods for these infections.
Christina Le, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.